Pharmacology, Toxicology and Pharmaceutical Science
Drug Screening
50%
Bronchiectasis
50%
Phosphodiesterase IV Inhibitor
50%
Beclometasone
50%
Cystic Fibrosis
50%
Drug Repositioning
50%
Randomized Controlled Trial
50%
Placebo
50%
Forskolin
50%
Chronic Cough
50%
Formoterol
50%
Interferon
50%
Complement Component C1q
50%
Biological Marker
50%
Ocular Tuberculosis
50%
Beta Adrenergic Receptor Stimulating Agent
25%
Asthma
25%
Chronic Obstructive Lung Disease
25%
Diseases
18%
Pharmacotherapy
12%
Repurposing
12%
Inflammation
12%
Protein Tyrosine Kinase Inhibitor
12%
Uveitis
12%
Comorbidity
12%
Cohort Study
6%
Clinical Feature
6%
Recurrent Disease
6%
Pathophysiology
6%
Eye Inflammation
6%
Medicine and Dentistry
Cystic Fibrosis
100%
Diseases
58%
Drug Screening
50%
Organoid
50%
Atypical Mycobacterium
50%
Cohort Effect
50%
Formoterol
50%
Drug Repositioning
50%
Bronchiectasis
50%
Chronic Cough
50%
Beclometasone
50%
Randomized Controlled Trial
50%
Placebo
50%
Phosphodiesterase IV Inhibitor
33%
Forskolin
33%
Chronic Obstructive Pulmonary Disease
25%
Beta Adrenergic Receptor Stimulating Agent
25%
Asthma
25%
Prevalence
20%
Serositis
12%
Comorbidity
12%
Tyrosine-Kinase Inhibitor
8%
Drug Therapy
8%
Infection
5%
Mycobacterium Avium-Intracellulare Infection
5%
Culture Conversion
5%
Life Expectancy
5%
Silo-Filler's Disease
5%
Pathogen
5%
Lung
5%
Nursing and Health Professions
Beclometasone
50%
Chronic Cough
50%
Bronchiectasis
50%
Formoterol
50%
Placebo
50%
Asthma
25%
Beta-Adrenergic Agonist
25%
Obstructive Lung Disease
25%
Clinical Audit
12%
Inflammation
12%
Comorbidity
12%
